VORICONAZOLE
ANTIFUNGALS-SYSTEMIC · DISSEMINATED CANDIDIASIS ·+6
AUROBINDO PHARM
Drug class
Antifungals-Systemic
Systemic antifungals comprise a diverse therapeutic group of medications administered orally or parenterally to treat internal, invasive, or severe fungal infections throughout the body. Read more about Antifungals-Systemic
205 drugs in this class 99 manufacturers
Drugs in Antifungals-Systemic
VORICONAZOLE
ANTIFUNGALS-SYSTEMIC · DISSEMINATED CANDIDIASIS ·+6
Amneal Pharmaceuticals
ITRACONAZOLE
ANTIFUNGALS-SYSTEMIC · TOENAIL ONYCHOMYCOSIS ·+4
Amneal Pharmaceuticals
VORICONAZOLE
ANTIFUNGALS-SYSTEMIC · DISSEMINATED CANDIDIASIS ·+6
AJANTA PHARMA L
VORICONAZOLE
ANTIFUNGALS-SYSTEMIC · DISSEMINATED CANDIDIASIS ·+6
SOLCO HEALTHCAR
VORICONAZOLE
ANTIFUNGALS-SYSTEMIC · DISSEMINATED CANDIDIASIS ·+6
NORTHSTAR RX LL
VORICONAZOLE
ANTIFUNGALS-SYSTEMIC · DISSEMINATED CANDIDIASIS ·+6
LUPIN PHARMACEU
VORICONAZOLE
ANTIFUNGALS-SYSTEMIC · DISSEMINATED CANDIDIASIS ·+6
LUPIN PHARMACEU
ITRACONAZOLE
ANTIFUNGALS-SYSTEMIC · TOENAIL ONYCHOMYCOSIS ·+4
ALEMBIC PHARMAC
Filter & compare in the drug finder →
Opens the drug finder with Antifungals-Systemic preselected. Add indication or manufacturer filters there.
Systemic antifungals comprise a diverse therapeutic group of medications administered orally or parenterally to treat internal, invasive, or severe fungal infections throughout the body.
Spanning multiple chemical classes—including triazoles, echinocandins, polyenes, and allylamines—these agents exert fungicidal or fungistatic activity by disrupting vital fungal cell structures, primarily by inhibiting ergosterol biosynthesis, binding directly to membrane ergosterol, or blocking fungal cell wall synthesis.
Clinically, systemic antifungals are essential for treating life-threatening invasive candidiasis, invasive aspergillosis, cryptococcal meningitis, and endemic mycoses, as well as managing recalcitrant mucocutaneous infections and providing targeted prophylaxis in immunocompromised patient populations.
-
nih.gov
Systemic antifungals comprise a diverse therapeutic group of medications administered orally or parenterally to treat internal, invasive, or severe fungal infections throughout the body Clinically, systemic antifungals are essential for treating life-threatening invasive candidiasis, invasive aspergillosis, cryptococcal meningitis, and endemic mycoses, as well as managing recalcitrant mucocutaneous infections and providing targeted prophylaxis in immunocompromised patient populations
-
nih.gov
Spanning multiple chemical classes—including triazoles, echinocandins, polyenes, and allylamines—these agents exert fungicidal or fungistatic activity by disrupting vital fungal cell structures, primarily by inhibiting ergosterol biosynthesis, binding directly to membrane ergosterol, or blocking fungal cell wall synthesis
-
cdc.gov
Spanning multiple chemical classes—including triazoles, echinocandins, polyenes, and allylamines—these agents exert fungicidal or fungistatic activity by disrupting vital fungal cell structures, primarily by inhibiting ergosterol biosynthesis, binding directly to membrane ergosterol, or blocking fungal cell wall synthesis
-
news-medical.net
Spanning multiple chemical classes—including triazoles, echinocandins, polyenes, and allylamines—these agents exert fungicidal or fungistatic activity by disrupting vital fungal cell structures, primarily by inhibiting ergosterol biosynthesis, binding directly to membrane ergosterol, or blocking fungal cell wall synthesis
-
nih.gov
Clinically, systemic antifungals are essential for treating life-threatening invasive candidiasis, invasive aspergillosis, cryptococcal meningitis, and endemic mycoses, as well as managing recalcitrant mucocutaneous infections and providing targeted prophylaxis in immunocompromised patient populations
-
nih.gov
Clinically, systemic antifungals are essential for treating life-threatening invasive candidiasis, invasive aspergillosis, cryptococcal meningitis, and endemic mycoses, as well as managing recalcitrant mucocutaneous infections and providing targeted prophylaxis in immunocompromised patient populations
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.